General
Preferred name
ESATENOLOL
Synonyms
S(-)-Atenolol ()
S-(-)-Atenolol ()
(R)-(+)-Atenolol ()
(S)-Atenolol ()
(S)-(-)-Atenolol ()
Atenolol, (s)- ()
(-)-atenolol ()
S-Atenolol ()
(s)-atenolol ()
Atenolol, (-)- ()
P&D ID
PD002800
CAS
93379-54-5
56715-13-0
Tags
available
drug
Drug Status
approved
experimental
investigational
Max Phase
2.0
Drug indication
Cardiovascular disease
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
DESCRIPTION (S)-Atenolol is a potent beta-adrenoreceptor blocker. (S)-Atenolol has the potential for the research of cardiovascular disorder[1].
PRICE 160
DESCRIPTION beta1 adrenoceptor antagonist (LOPAC library)
DESCRIPTION β1-antagonist. Active isomer of atenolol (Cat. No. 0387) (Tocriscreen Total)
DESCRIPTION (S)-(-)-Atenolol is the active enantiomer of (RS)-atenolol, which is a cardioselective β-adrenergic blocker. It has antihypertensive, antianginal, antiarrhythmic (class II) effects. (BOC Sciences Bioactive Compounds)
DESCRIPTION (S)-(-)-Atenolol has beta-adrenergic blocking effects. (TargetMol Bioactive Compound Library)
Compound Sets
11
BOC Sciences Bioactive Compounds
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugCentral
DrugCentral Approved Drugs
LOPAC library
MedChem Express Bioactive Compound Library
Prestwick Chemical Library
TargetMol Bioactive Compound Library
Tocriscreen Total
External IDs
27
Properties
(calculated by RDKit )
Molecular Weight
266.16
Hydrogen Bond Acceptors
4
Hydrogen Bond Donors
3
Rotatable Bonds
8
Ring Count
1
Aromatic Ring Count
1
cLogP
0.45
TPSA
84.58
Fraction CSP3
0.5
Chiral centers
1.0
Largest ring
6.0
QED
0.64
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Selectivity
beta1
Target
β-adrenergic receptor
Adrenergic Receptor
Indication
hypertension
MOA
Adrenergic Receptor antagonist
Pathway
GPCR/G protein
Neuroscience
Neuronal Signaling
Source data